HaemaLogiX's CMDO, Tertia Dex will be speaking at the Women in BIO and Health – Industry and Networking Forum to be held on Wednesday 8 May 2024, at UniSC Moreton Bay, Petrie, Queensland.
Read article +Today, on Rare Disease Day, we reflect on the courage and resilience of those facing the challenges of rare medical conditions.
Read article +HaemaLogiX Ltd, a clinical stage biotech, is pleased to announce the appointment of Laurence Turka, M.D. to its board as a non-executive director.
Read article +HaemaLogiX Ltd, a clinical stage biotech, is pleased to announce the appointment of Professor of Medicine and of Laboratory Medicine and Pathology Angela Dispenzieri, M.D. to its Scientific Advisory Board (SAB).
Read article +HaemaLogiX’s South Korean patent 'Kappa Myeloma Antigen Chimeric Receptors and Uses Thereof' was granted in South Korea on 5 January 2024.
Read article +